We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
First Watch Restaurant Group
FWRG
$742M
| $321K | 0.02% |
+19,274
| New | +$371K |
|
677
UMB Financial
UMBF
$11.1B
| $320K | 0.02% |
+3,170
| New | +$349K |
|
678
Cedar Fair
FUN
$1.62B
| $320K | 0.02% |
8,977
-5,361
| -37% | -$228K |
|
679
BGC Group
BGC
$4.86B
| $320K | 0.02% |
+34,910
| New | +$327K |
|
680
Grab
GRAB
$15B
| $320K | 0.02% |
70,659
+25,188
| +55% | +$118K |
|
681
JB Hunt Transport Services
JBHT
$25B
| $318K | 0.02% |
2,147
-23,695
| -92% | -$3.9M |
|
|
ILPT
682
Industrial Logistics Properties Trust
ILPT
$583M
| $318K | 0.02% |
92,304
| – | – |
|
|
SCS
683
DELISTED
Steelcase
SCS
| $317K | 0.02% |
28,913
+5,434
| +23% | +$62.7K |
|
684
Valmont Industries
VMI
$9.5B
| $316K | 0.02% |
1,107
-1,353
| -55% | -$441K |
|
685
iShares China Large-Cap ETF
FXI
$4.35B
| $315K | 0.02% |
+8,800
| New | +$298K |
|
686
VF Corp
VFC
$5.86B
| $315K | 0.02% |
+20,302
| New | +$450K |
|
687
e.l.f. Beauty
ELF
$5.62B
| $315K | 0.02% |
+5,010
| New | +$436K |
|
688
Corning
GLW
$136B
| $314K | 0.02% |
6,866
-3,335
| -33% | -$165K |
|
689
Trevi Therapeutics
TRVI
$2.54B
| $314K | 0.02% |
+49,937
| New | +$238K |
|
690
Talos Energy
TALO
$2.6B
| $314K | 0.02% |
32,300
+3,700
| +13% | +$35.1K |
|
691
Mueller Industries
MLI
$15.2B
| $313K | 0.02% |
+8,218
| New | +$328K |
|
692
Crane Co
CR
$12.7B
| $313K | 0.02% |
+2,042
| New | +$328K |
|
693
Sabesp
SBS
$18.3B
| $311K | 0.02% |
+89,899
| New | +$286K |
|
694
Xperi
XPER
$332M
| $309K | 0.02% |
40,080
+6,159
| +18% | +$53.9K |
|
695
ConocoPhillips
COP
$148B
| $309K | 0.02% |
2,946
-3,142
| -52% | -$313K |
|
696
Eastman Chemical
EMN
$8.39B
| $309K | 0.02% |
3,503
-2,337
| -40% | -$221K |
|
697
PNC Financial Services
PNC
$100B
| $308K | 0.02% |
1,754
-220
| -11% | -$41.5K |
|
698
PayPal
PYPL
$50.5B
| $308K | 0.02% |
4,723
-609
| -11% | -$47.4K |
|
699
Marriott Vacations Worldwide
VAC
$3.89B
| $308K | 0.02% |
+4,794
| New | +$381K |
|
700
ITT
ITT
$18.9B
| $308K | 0.02% |
+2,384
| New | +$340K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.